Emerging evidence suggested that inhibition of ileal FXR-FGF15 induced beneficial effects that can lead to the improvement of non-alcoholic fatty liver disease (NAFLD), obesity, and insulin resistance12–14. Here, NR1H4 is linked to obesity disorder.